| 产品详情 |
| Edit |   |
|---|
| Product Name | Adenosine Receptor Agonist, NECA |
|---|
| Description | Purity ~99% (HPLC). A cell-permeable adenosine analog that acts a potent non-selective agonist of adenosine receptors (Ki = 14nM, 20nM, 2.4uM and 6.2nM for A1, A2A, A2B, A3, respectively). Increases intracellular cAMP production (EC50 = 3.1uM in A2B expressing CHO cells). Shown to increase glucagon release in a dose-dependent manner and inhibit insulin release at low concentrations. Although at higher concentration some insulin release is observed. Also, displays a wide range adenosine-dependent effects, such as blocking platelet aggregation and inhibiting DNA synthesis. When administered at reperfusion, it is shown reduce infarction and block the formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Solubility: DMSO Molar Mass: 308.3 Primary Target Ki: 14nM |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Adenosine Receptor Agonist, NECA ((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217157 |
|---|
| Price | |
|---|
| Order / More Info | Adenosine Receptor Agonist, NECA from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|